8666 J . Org. Chem., Vol. 65, No. 25, 2000
Feldman and Wrobleski
Procedure B (CH2Cl2 as solvent, -42 °C f room temperature),
alkynylstannane 20a (0.11 g, 0.23 mmol) was converted into
52 mg (65%) of 21 as a white solid, mp 86-87 °C: IR (KBr)
Anal. Calcd for C17H22O4S: C, 63.33; H, 6.88. Found: C, 63.00;
H, 6.94. In addition, 8 mg (16%) of 22 was isolated as a white
solid.
1
1558, 1312 cm-1; H NMR (200 MHz, CDCl3) 7.76 (d, J ) 8.2
cis-3-Meth yl-2-[3-(tolu en e-4-su lfon yl)-4,5-dih ydr ofu r an -
2-yl]tetr a h yd r op yr a n (29b). Using General Procedure B, the
alkynylstannane 20g (0.11 g, 0.24 mmol) was converted into
32 mg of dihydrofurans 29a /b (41%, 8.5:1 mixture of 29b to
29a ) as a white solid following chromatographic purification
with the solvent gradient 20% EtOAc/hexanes, 25% EtOAc/
hexanes, and 30% EtOAc/hexanes. The ratio of isomers was
calculated by averaging the integration ratios of the methyl
doublets and the C(H)O protons in the 1H NMR spectrum of
the crude product mixture. Partial purification of the indi-
vidual isomers was achieved through the aforementioned
chromatography.
Hz, 2 H), 7.32 (d, J ) 7.9 Hz, 2 H), 4.40 (t, J ) 10.0 Hz, 2 H),
2.78 (t, J ) 10.0 Hz, 2 H), 2.43 (s, 3 H), 0.99 (s, 9 H), 0.36 (s,
6 H); 13C NMR (75 MHz, CDCl3) 173.7, 143.5, 138.5, 129.6,
127.3, 125.5, 72.1, 31.3, 26.8, 21.5, 17.5, -5.0; MS m/e (+CI)
339 (MH+, 7). Anal. Calcd for C17H26O3SSi: C, 60.31; H, 7.74.
Found: C, 60.14; H, 7.69.
4-(Tolu en e-4-su lfon yl)-2,3-d ih yd r ofu r a n (22). A 1 M
solution of n-Bu4NF in THF (62 µL, 0.062 mmol) was added
to the silylalkene 21 (21 mg, 0.062 mmol) in 5 mL of THF.
After stirring for 30 min at room temperature, 1 M NH4Cl
solution was added, and the aqueous phase was extracted with
Et2O. The combined organic layers were washed with H2O and
then brine, dried over Na2SO4, filtered, and concentrated to
obtain 19 mg of a white solid, mp 106-107 °C: IR (film) 1607
Da ta for 29b: IR (film) 1622 cm-1 1H NMR (360 MHz,
;
C6D6) 7.89 (d, J ) 8.2 Hz, 2 H), 6.79 (d, J ) 8.7 Hz, 2 H), 5.65
(d, J ) 3.6 Hz, 1 H), 3.87 (dt, J ) 11.5, 3.6 Hz, 1 H), 3.69-
3.42 (m, 3 H), 2.64-2.54 (m, 1 H), 2.32-2.22 (m, 2 H), 1.88 (s,
3 H), 1.71-1.45 (m, 3 H), 1.10-1.05 (m, 1 H) with overlapping
1.08 (d, J ) 7.3 Hz, 3 H); 13C NMR (90 MHz, C6D6) 167.8, 143.6,
140.5, 130.1, 127.8, 111.2, 73.9, 70.3, 68.0, 33.3, 30.8, 30.2, 22.7,
21.5, 15.0; MS m/e (+CI) 323 (MH+, 100). Anal. Calcd for
1
cm-1; H NMR (200 MHz, CDCl3) 7.77 (d, J ) 8.2 Hz, 2 H),
7.32 (d, J ) 8.0 Hz, 2 H), 7.19 (t, J ) 1.8 Hz, 1 H), 4.59 (t, J
) 9.6 Hz, 2 H), 2.78 (dt, J ) 9.6, 1.7 Hz, 2 H), 2.43 (s, 3 H);
13C NMR (100 MHz, CDCl3)156.3, 144.0, 137.8,129.7, 127.3,
117.6, 74.0, 28.1, 21.6; MS m/e (+FAB/3NBA) 225 (MH+, 70).
Anal. Calcd for C11H12O3S: C, 58.91; H, 5.39. Found: C, 58.80;
H, 5.54.
C
17H22O4S: C, 63.33; H, 6.88. Found: C, 62.86; H, 6.93. In
addition,8 mg (16%) of 22 was isolated as a white solid.
2-[3-(Tolu en e-4-su lfon yl)-4,5-d ih yd r ofu r a n -2-yl]-[1,3]-
d ioxa n e (31). Using General Procedure B, the alkynylstan-
nane 20h (0.12 g, 0.27 mmol) was converted into 56 mg of
dihydrofuran 31 (68%) as a white solid following chromato-
graphic purification with the solvent gradient 15% Et2O/
hexanes, 20% Et2O/hexanes, 25% Et2O/hexanes, 30% Et2O/
hexanes and 50% EtOAc/hexanes, mp 184-185 °C: IR (film)
3′-(Tolu en e-4-su lfon yl)-2,3,4,5,4′,5′-h exa h yd r o[2,2′]b i-
fu r a n yl (27). Using General Procedure B, the alkynylstan-
nane 20d (0.11 g, 0.26 mmol) was converted into 26 mg of
dihydrofuran 27 (35%) as a white solid following chromato-
graphic purification with the gradient 20% Et2O/hexanes, 25%
Et2O/hexanes, and 30% Et2O/hexanes, mp 111-112 °C: IR
1
(film) 1628 cm-1; H NMR (400 MHz, CDCl3) 7.77 (d, J ) 8.0
1
Hz, 2 H), 7.32 (d, J ) 8.0 Hz, 2 H), 5.54 (t, J ) 6.0 Hz, 1 H),
4.43 (t, J ) 11.0 Hz, 2 H), 3.97-3.87 (m, 2 H), 3.01-2.93 (m,
1 H), 2.78-2.70 (m, 1H), 2.43 (s, 3 H), 2.31-2.25 (m, 1 H),
2.08-1.93 (m, 3 H); 13C NMR (100 MHz, CDCl3) 167.9, 144.0,
138.5, 129.9, 127.2, 110.7, 71.5, 70.5, 69.8, 30.8, 30.5, 26.5, 21.7;
MS m/e (+CI) 295 (MH+, 54). Anal. Calcd for C15H18O4S: C,
61.21; H, 6.16. Found: C, 61.20; H, 6.32. In addition, 15 mg
(25%)of 22 was isolated as a white solid.
1647 cm-1; H NMR (300 MHz, C6D6) 7.93 (d, J ) 8.7 Hz, 2
H), 6.81 (d, J ) 7.9 Hz, 2 H), 6.59 (s, 1 H), 3.83 (dd, J ) 10.6,
4.9 Hz, 2 H), 3.61-3.51 (m, 4 H), 2.31 (t, J ) 10.2 Hz, 2 H),
1.90-1.77 (m, 1 H) with overlapping 1.88 (s, 3 H), 0.57-0.53
(m, 1 H); 13C NMR (75 MHz, C6D6) 161.6, 143.4, 139.7, 129.8,
128.1, 113.0, 94.2, 70.3, 67.2, 30.5, 25.8, 21.1; MS m/e (+CI)
311 (MH+, 100). Anal. Calcd for C15H18O5S: C, 58.05; H, 5.84.
Found: C, 58.19; H, 6.03.
2-[3-(Tolu en e-4-su lfon yl)-4,5-dih ydr ofu r an -2-yl]tetr ah y-
d r op yr a n (26). Using General Procedure B, the alkynylstan-
nane 20e (0.15 g, 0.34 mmol) was converted into 42 mg of
dihydrofuran 26 (41%) as a white solid following chromato-
graphic purification with 25% EtOAc/hexanes, mp 98 °C
(decomp): IR (film) 1629 cm-1; 1H NMR (400 MHz, CDCl3) 7.76
(d, J ) 8.5 Hz, 2 H), 7.33 (d, J ) 8.0 Hz, 2 H), 5.09-5.06 (m,
1 H), 4.51-4.40 (m, 2 H), 4.08 (dd, J ) 11.0, 4.0 Hz, 1 H), 3.60
(dd, J ) 11.5, 2.5 Hz, 1 H), 2.99-2.91 (m, 1 H), 2.78-2.70 (m,
1 H), 2.44 (s, 3 H), 1.93-1.89 (m, 1 H), 1.77-1.54 (m, 5 H);
13C NMR (75 MHz, CDCl3) 166.2, 143.9, 138.4, 129.7, 127.1,
109.7, 71.5, 70.6, 68.9, 30.3, 29.4, 25.4, 23.0, 21.6; MS m/e (+CI)
309 (MH+, 100). Anal. Calcd for C16H20O4S: C, 62.31; H, 6.54.
Found: C, 62.46; H, 6.62. In addition,21 mg (27%) of 22 was
isolated as a white solid.
2-2H-2-([1,1-2H2]-Bu t-3-yn yloxy)tetr a h yd r op yr a n (38).
A 1-2 M hexanes solution of 6-deuteriodihydropyran18b (10
mL) and p-toluenesulfonic acid monohydrate (68 mg, 0.36
mmol) was added to [1,1-2H2]-but-3-ynol18a (0.26 g, 3.6 mmol)
in 5 mL of CH2Cl2. After 2 h, the reaction mixture was treated
with 5 mL of saturated sodium bicarbonate solution and
diluted with 50 mL of Et2O. The phases were separated, and
the organic layer was washed with 10 mL of H2O and brine,
dried over anhydrous Na2SO4, filtered, and concentrated in
vacuo to provide a yellow oil. Purification of the crude product
by flash chromatography on silica gel eluting with 5% Et2O/
hexanes afforded 329 mg (58%) of 38 as a colorless oil: IR (film)
1
3295, 2107 cm-1; H NMR (300 MHz, C6D6) 3.79-3.71 (m, 1
H), 3.38-3.32 (m, 1 H), 2.30 (s, 2 H), 1.75 (t, J ) 2.6 Hz, 1 H)
overlapping 1.75-1.70 (m, 1 H), 1.55-1.49 (m, 2 H), 1.33-
1.19 (m, 3 H); 13C NMR (75 MHz, C6D6) 98.0 (t), 81.7, 69.6,
64.8 (q), 61.4, 30.6, 25.8, 20.1, 19.3; MS m/e (+CI) 158 (MH+,
6); HRMS (+CI) calcd for C9H12D3O2 (MH+)158.1260, found
158.1263.
tr a n s-3-Meth yl-2-[3-(tolu en e-4-su lfon yl)-4,5-d ih yd r ofu -
r a n -2-yl]tetr a h yd r op yr a n (29a ). Using General Procedure
B, the alkynylstannane 20f (0.10 g, 0.22 mmol) was converted
into 30 mg of dihydrofurans 29a /b (43%, 10:1 mixture of 29a
to 29b) as a white solid following chromatographic purification
with the solvent gradient 20% EtOAc/hexanes, 25% EtOAc/
hexanes, and 30% EtOAc/hexanes. The ratio of isomers was
calculated by averaging the integration ratios of the methyl
doublets and the C(H)O protons in the 1H NMR spectrum of
the crude product mixture. Partial purification of the indi-
vidual isomers was achieved through the aforementioned
chromatography.
Tr ibu tyl[[4,4-2H2]-4-([2-2H]-tetr a h yd r op yr a n -2-yloxy)-
bu t-1-yn yl]sta n n a n e (39). Using General Procedure A, the
trideuterated but-3-ynyl ether 38 (0.16 g, 1.0 mmol) was
converted to 320 mg of alkynylstannane 39 (72%) following
purification of the crude product with 3% Et2O/hexanes: IR
1
(film) 2154 cm-1; H NMR (300 MHz, C6D6) 3.83-3.75 (m, 1
H), 3.36 (ddt, J ) 15.7, 4.1, 1.5 Hz, 1 H), 2.56 (s, 2 H), 1.79-
1.18 (m, 16 H), 1.01 (t, J ) 7.9 Hz, 6 H), 0.93 (t, J ) 7.2 Hz,
9 H); 13C NMR (75 MHz, C6D6) 108.8 (J C-Sn119 ) 36.3 Hz), 97.8
(t), 82.7, 65.6 (pentet), 61.3, 30.7, 29.3 (J C-Sn119 ) 11.6 Hz),
27.4 (J C-Sn119 ) 29.8 Hz), 25.9, 22.0, 19.3, 13.9, 11.2 (J C-Sn119
Da ta for 29a : IR (film) 1622 cm-1 1H NMR (360 MHz,
;
C6D6) 7.95 (d, J ) 8.2 Hz, 2 H), 6.81 (d, J ) 8.7 Hz, 2 H), 5.11
(d, J ) 10.0 Hz, 1 H), 3.93-3.89 (m, 1 H), 3.68-3.53 (m, 2 H),
3.42-3.35 (m, 1 H), 2.65-2.56 (m, 1 H), 2.34-2.22 (m, 1 H),
2.01-1.87 (m, 1 H), 1.88 (s, 3 H), 1.59-1.49 (m, 2 H), 1.16-
1.03 (m, 2 H) 0.92 (d, J ) 6.4 Hz, 3 H); 13C NMR (90 MHz,
C6D6) 165.1, 143.2, 140.1, 129.7, 128.5, 113.6, 76.6, 69.8, 68.6,
32.7, 32.1, 30.8, 26.6, 21.1, 17.8; MS m/e (+CI) 323 (MH+, 100).
) 191.8 Hz, J C-Sn117 ) 183.1 Hz; MS m/e (+CI) 448 (Sn120
)
(MH+, 5); HRMS (+CI) calcd for C21H38D3O2Sn120 (MH+)
448.2317, found 448.2305.
[2,2-2H2]-δ-Va ler ola cton e (41). Sodium methoxide (0.28 g,
5.2 mmol) was added to 5-benzyloxypentanoic acid methyl